A bit underwhelming and I'm not surprised though I was hoping for more like everybody else, but a step in the right direction. To state the obvious, Elanco clearly wants to secure the world wide rights for the veterinary market if the clinical trials go well.
Add to My Watchlist
What is My Watchlist?
